| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
39,709 |
28,592 |
$7.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,707 |
10,079 |
$154K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,437 |
1,852 |
$26K |
| 90834 |
Psychotherapy, 45 minutes with patient |
5,344 |
3,389 |
$23K |
| 90832 |
Psychotherapy, 30 minutes with patient |
3,017 |
2,153 |
$16K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,100 |
1,051 |
$15K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
668 |
646 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
666 |
609 |
$7K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
453 |
365 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
106 |
97 |
$4K |
| 90791 |
Psychiatric diagnostic evaluation |
286 |
278 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
395 |
380 |
$4K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,336 |
849 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
876 |
427 |
$2K |
| 99381 |
|
57 |
52 |
$1K |
| 59430 |
|
14 |
13 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
475 |
426 |
$824.05 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
284 |
277 |
$795.43 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
449 |
423 |
$793.34 |
| 81003 |
|
4,040 |
2,936 |
$775.59 |
| 87807 |
|
153 |
145 |
$492.69 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
133 |
103 |
$442.12 |
| 97803 |
|
592 |
532 |
$306.47 |
| 81025 |
|
83 |
78 |
$281.98 |
| 90670 |
|
740 |
707 |
$170.34 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,131 |
2,026 |
$92.13 |
| 99406 |
|
358 |
307 |
$67.08 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
14 |
$59.84 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,341 |
1,280 |
$26.32 |
| 97802 |
|
505 |
433 |
$25.82 |
| 90633 |
|
107 |
102 |
$0.02 |
| 90697 |
|
290 |
277 |
$0.01 |
| 90681 |
|
194 |
186 |
$0.01 |
| 90715 |
|
13 |
12 |
$0.01 |
| 2010F |
|
3,980 |
3,255 |
$0.00 |
| 0500F |
|
62 |
60 |
$0.00 |
| 90474 |
|
169 |
161 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
644 |
540 |
$0.00 |
| 3292F |
|
124 |
115 |
$0.00 |
| 96127 |
|
768 |
671 |
$0.00 |
| 3074F |
|
1,725 |
1,365 |
$0.00 |
| 2000F |
|
3,644 |
2,907 |
$0.00 |
| 3351F |
|
725 |
601 |
$0.00 |
| 0501F |
|
1,369 |
978 |
$0.00 |
| 1034F |
|
318 |
273 |
$0.00 |
| 3352F |
|
359 |
300 |
$0.00 |
| 3079F |
|
852 |
717 |
$0.00 |
| 3008F |
|
4,616 |
3,727 |
$0.00 |
| 3075F |
|
478 |
394 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
84 |
68 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
36 |
$0.00 |
| 3080F |
|
254 |
219 |
$0.00 |
| 2001F |
|
2,137 |
1,718 |
$0.00 |
| 3353F |
|
238 |
197 |
$0.00 |
| 0503F |
|
181 |
164 |
$0.00 |
| 3044F |
|
140 |
124 |
$0.00 |
| 90677 |
|
35 |
30 |
$0.00 |
| 3294F |
|
42 |
39 |
$0.00 |
| 90723 |
|
114 |
107 |
$0.00 |
| 3048F |
|
16 |
12 |
$0.00 |
| 36416 |
|
14 |
12 |
$0.00 |
| 90686 |
|
85 |
76 |
$0.00 |
| 88720 |
|
15 |
12 |
$0.00 |
| 1125F |
|
13 |
12 |
$0.00 |
| 1036F |
|
15 |
15 |
$0.00 |
| 3028F |
|
2,938 |
2,416 |
$0.00 |
| 90648 |
|
220 |
204 |
$0.00 |
| 4120F |
|
1,251 |
1,177 |
$0.00 |
| 0502F |
|
2,249 |
1,586 |
$0.00 |
| 3078F |
|
1,490 |
1,195 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,820 |
2,183 |
$0.00 |
| 1159F |
|
240 |
205 |
$0.00 |
| 3077F |
|
379 |
339 |
$0.00 |
| 3293F |
|
61 |
55 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
83 |
67 |
$0.00 |
| 90710 |
|
76 |
73 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
159 |
147 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
187 |
161 |
$0.00 |
| 90461 |
|
125 |
117 |
$0.00 |
| 90671 |
|
118 |
114 |
$0.00 |
| 4145F |
|
46 |
34 |
$0.00 |
| 99173 |
|
71 |
66 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
14 |
14 |
$0.00 |
| 90785 |
|
18 |
14 |
$0.00 |